$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卢卡帕利(rucaparib)的注意事项和药物相互作用
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的购买渠道
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗难治性转移性结直肠癌建议采用剂量递增策略
2025-10-19 11:44:20
Check Details
结直肠癌的检查项目有哪些?
2025-10-19 11:44:20
Check Details
晚期转移性结直肠癌新选择—瑞格非尼
2025-10-19 11:44:20
Check Details
结直肠癌的病因都有哪些?
2025-10-19 11:44:20
Check Details
结直肠癌患者术后护理注意事项
2025-10-19 11:44:20
Check Details
溃疡性结肠炎患者谨慎服用托法替尼
2025-10-19 11:44:20
Check Details
阿柏西普(Zaltrap)治疗转移性结直肠癌
2025-10-19 11:44:20
Check Details
瑞格非尼可以延长结直肠癌生存期
2025-10-19 11:44:20
Check Details
结直肠癌术后护理
2025-10-19 11:44:20
Check Details
如何预防结直肠癌?
2025-10-19 11:44:20
Check Details
1
2
...
1589
1590
1591
1592
1593
1594
1595
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Lapatinib: Proper Administration Guide and Key Precautions
4
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
5
Cemiplimab Storage and Handling Guide
6
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
7
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
8
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
9
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
10
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
11
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
12
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors